Journal article

STAT3 signaling mediates tumour resistance to EGFR targeted therapeutics

Ahmad A Zulkifli, Fiona H Tan, Tracy L Putoczki, Stanley S Stylli, Rodney B Luwor

Molecular and Cellular Endocrinology | ELSEVIER IRELAND LTD | Published : 2017

DOI: 10.1016/j.mce.2017.01.010

Grants

Awarded by Worldwide Cancer Research

Citation metrics

20Web of Science
20Scopus
23Dimensions

Keywords

Science & Technology
Colorectal Neoplasms
Erbb Receptors
Epidermal-Growth-Factor
Breast-Cancer
Signal Transduction
Epithelial-Mesenchymal Transition
Cell Lung-Cancer
Gene Expression Regulation, Neoplastic
Life Sciences & Biomedicine
Proto-Oncogene Proteins P21(ras)
Therapeutics
Cell Biology
Human Bladder-Cancer
Carcinoma, Non-Small-Cell Lung
Humans
Acquired-Resistance
Cancer
Neoplasm Invasiveness
Molecular Targeted Therapy
In-Vivo
Cell Proliferation
Stat3 Transcription Factor
Endocrinology & Metabolism
Metastatic Colorectal-Cancer
Antineoplastic Agents
Drug Resistance, Neoplasm
Egfr
Factor Receptor
Gefitinib Resistance
Protein Kinase Inhibitors
Stat3